Combined taVNS and tDCS in Subacute Stroke Patients

Recruiting N/A Interventional Study
Ischemic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
80 (estimated)
Sponsor
National Cheng-Kung University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Ischemic stroke, the most prevalent neurological disorder, is treated with medication and thrombectomy but with limited success, especially in chronic stages where traditional rehabilitation is the primary option. Stroke often leads to post-stroke autonomic imbalance, deteriorating functional outcomes and increasing recurrence risk. Emerging non-pharmacological treatments like Transcutaneous Auric…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years old * Subacute ischemic stroke patients within 7-30 days after stroke symptoms is stabilized * Stroke will be documented by DWI-MRI * Lesion locations at least involve supratentorial area * Patients have unilateral weakness documented with manual muscle testing …
Contacts

Pi-Shan Sung, MD,PhD

+886-62353535

pishansung@gmail.com

CONTACT

Chou-Ching Lin, MD,PhD

+886-62353535

cxl45@mail.ncku.edu.tw

CONTACT